Literature DB >> 27168431

Drug Regulation and Pricing--Can Regulators Influence Affordability?

Hans-Georg Eichler1, Hugo Hurts1, Karl Broich1, Guido Rasi1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27168431     DOI： 10.1056/NEJMp1601294

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Transparent Reporting on Research Using Unstructured Electronic Health Record Data to Generate 'Real World' Evidence of Comparative Effectiveness and Safety.

Authors:  Shirley V Wang; Olga V Patterson; Joshua J Gagne; Jeffrey S Brown; Robert Ball; Pall Jonsson; Adam Wright; Li Zhou; Wim Goettsch; Andrew Bate
Journal:  Drug Saf       Date:  2019-11       Impact factor: 5.606

2.  Precision medicine and the changing role of regulatory agencies.

Authors:  Alasdair Breckenridge; Hans-Georg Eichler; Jonathan P Jarow
Journal:  Nat Rev Drug Discov       Date:  2016-10-14       Impact factor: 84.694

Review 3.  The Value of Medicines: A Crucial but Vague Concept.

Authors:  Fernando Antoñanzas; Robert Terkola; Maarten Postma
Journal:  Pharmacoeconomics       Date:  2016-12       Impact factor: 4.981

4.  Integrating health technology assessment requirements in the clinical development of medicines: the experience from NICE scientific advice.

Authors:  François Maignen; Leeza Osipenko; Pilar Pinilla-Dominguez; Emily Crowe
Journal:  Eur J Clin Pharmacol       Date:  2016-12-10       Impact factor: 2.953

Review 5.  The value of anticancer drugs - a regulatory view.

Authors:  Francesco Pignatti; Ulla Wilking; Douwe Postmus; Nils Wilking; Julio Delgado; Jonas Bergh
Journal:  Nat Rev Clin Oncol       Date:  2021-12-06       Impact factor: 66.675

6.  Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.

Authors:  Michael Ermisch; Anna Bucsics; Patricia Vella Bonanno; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Jurij Fürst; Kristina Garuolienė; Martin van der Graaff; Jolanta Gulbinovič; Alan Haycox; Jan Jones; Roberta Joppi; Ott Laius; Irene Langner; Antony P Martin; Vanda Markovic-Pekovic; Laura McCullagh; Einar Magnusson; Ellen Nilsen; Gisbert Selke; Catherine Sermet; Steven Simoens; Robert Sauermann; Ad Schuurman; Ricardo Ramos; Vera Vlahovic-Palcevski; Corinne Zara; Brian Godman
Journal:  Front Pharmacol       Date:  2016-09-28       Impact factor: 5.810

Review 7.  Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks.

Authors:  Toon van der Gronde; Carin A Uyl-de Groot; Toine Pieters
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

8.  TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases.

Authors:  Lieven Annemans; Amr Makady
Journal:  Orphanet J Rare Dis       Date:  2020-05-26       Impact factor: 4.123

9.  The financial transaction between counseling and nursing care service centers (CNCSCs) and their clients: a qualitative study.

Authors:  Sefollah Alaei; Fatemeh Alhani; Hassan Navipour
Journal:  BMC Health Serv Res       Date:  2018-04-12       Impact factor: 2.655

10.  Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.

Authors:  Shirley V Wang; Sebastian Schneeweiss; Marc L Berger; Jeffrey Brown; Frank de Vries; Ian Douglas; Joshua J Gagne; Rosa Gini; Olaf Klungel; C Daniel Mullins; Michael D Nguyen; Jeremy A Rassen; Liam Smeeth; Miriam Sturkenboom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-09       Impact factor: 2.890
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.